JHP Pharma in pact to produce life saving drugs
JHP’s Rochester Michigan manufacturing plant covers over 80 acres of land and includes a 171,000sqft production building and warehouse. JHP Pharma president and CEO Stuart Hinchen said their
HAYA Therapeutics has secured fast track designation from the US Food and Drug Administration (FDA) for its investigational therapy, HTX-001, to treat symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM).